Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly

被引:238
作者
Hayward, BE
Barlier, A
Korbonits, M
Grossman, AB
Jacquet, P
Enjalbert, A
Bonthron, DT
机构
[1] Univ Leeds, Mol Med Unit, Leeds, W Yorkshire, England
[2] Inst Jean Roche, Fac Med Nord, Lab Interact Cellulaires Neuroendocriniennes, Marseille, France
[3] St Bartholomews Hosp, Dept Endocrinol, London, England
[4] Ctr Hosp Univ Timone, Serv Endocrinol, Marseille, France
关键词
D O I
10.1172/JCI11887
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Approximately 40% of growth hormone-secreting pituitary adenomas have somatic mutations in the GNAS1 gene (the so-called gsp oncogene). These mutations at codon 201 or codon 227 constitutively activate the a subunit of the adenylate cyclase-stimulating G protein G(s). GNAS1 is subject to a complex pattern of genomic imprinting, its various promoters directing the production of maternally, paternally and biallelically derived gene products. Transcripts encoding G(s)alpha are biallelically derived in most human tissues. Despite this, we show here that in 21 out of 22 gsp-positive somatotroph adenomas, the mutation had occurred on the maternal allele. To investigate the reason for this allelic bias, we also analyzed GNAS1 imprinting in the normal adult pituitary and found that G(s)alpha is monoallelically expressed from the maternal allele in this tissue. We further show that this monoallelic expression of G(s)alpha is frequently relaxed in somatotroph tumors, both in those that have gsp mutations and in those that do not. These findings imply a possible role for loss of G(s)alpha imprinting during pituitary somatotroph tumorigenesis and also suggest that G(s)alpha imprinting is regulated separately from that of the other GNAS1 products, NESP55 and XL alphas, imprinting of which is retained in these tumors.
引用
收藏
页码:R31 / R36
页数:6
相关论文
共 44 条
  • [1] HUMAN FETAL ADENOHYPOPHYSIS - MORPHOLOGICAL AND FUNCTIONAL-ANALYSIS INVITRO
    ASA, SL
    KOVACS, K
    SINGER, W
    [J]. NEUROENDOCRINOLOGY, 1991, 53 (06) : 562 - 572
  • [2] Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone-secreting tumors
    Ballaré, E
    Mantovani, S
    Lania, A
    Di Blasio, AM
    Vallar, L
    Spada, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12) : 4386 - 4390
  • [3] Impact of gsp oncogene on the expression of genes coding for Gsα, Pit-1, Gi2α, and somatostatin receptor 2 in human somatotroph adenomas:: Involvement in octreotide sensitivity
    Barlier, A
    Pellegrini-Bouiller, I
    Gunz, G
    Zamora, AJ
    Jaquet, P
    Enjalbert, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) : 2759 - 2765
  • [4] Pronostic and therapeutic consequences of Gsα mutations in somatotroph adenomas
    Barlier, A
    Gunz, G
    Zamora, AJ
    Morange-Ramos, I
    Figarella-Branger, D
    Dufour, H
    Enjalbert, A
    Jaquet, P
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) : 1604 - 1610
  • [5] Barlier A, 1999, J NEUROENDOCRINOL, V11, P491
  • [6] PARENTAL ORIGIN OF TRANSCRIPTION FROM THE HUMAN GNAS1 GENE
    CAMPBELL, R
    GOSDEN, CM
    BONTHRON, DT
    [J]. JOURNAL OF MEDICAL GENETICS, 1994, 31 (08) : 607 - 614
  • [7] PSEUDOHYPOPARATHYROIDISM - DEFECTIVE EXCRETION OF 3',5'-AMP IN RESPONSE TO PARATHYROID HORMONE
    CHASE, LR
    MELSON, GL
    AURBACH, GD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (10) : 1832 - &
  • [8] IMPRINTING IN ALBRIGHT HEREDITARY OSTEODYSTROPHY
    DAVIES, SJ
    HUGHES, HE
    [J]. JOURNAL OF MEDICAL GENETICS, 1993, 30 (02) : 101 - 103
  • [9] Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma
    El-Naggar, AK
    Lai, SL
    Tucker, SA
    Clayman, GL
    Goepfert, H
    Hong, WK
    Huff, V
    [J]. ONCOGENE, 1999, 18 (50) : 7063 - 7069
  • [10] FARFEL Z, 1980, NEW ENGL J MED, V303, P237, DOI 10.1056/NEJM198007313030501